APEX ANAESTHESIA LIMITED
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-05-31 | 2024-05-31 |
|---|---|---|
| Average employees | 200 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (12 events)Click to expand
- 2025-09-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-06-03📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-02-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-05-09📄memorandum-articlesincorporation · MA
- 2024-05-09📄capital-name-of-class-of-sharescapital · SH08
- 2024-05-09📄resolutionresolution · RESOLUTIONS
- 2024-05-01📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2024-05-01📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-05-01📄capital-allotment-sharescapital · SH01
- 2023-05-26🏢Company incorporatedAs APEX ANAESTHESIA LIMITED
- 2023-05-26➕PARTRIDGE, Alastair Simon, Dr appointeddirector
- 2023-05-26📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.9 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Alastair Simon Partridge Individual · British · DOB 08/1979 · age 47 | 50–75% | 50–75% | 50-75% shares · 50-75% voting · trust interest | 26/05/2023 |
Mrs Lucinda Mary Cameron Partridge Individual · British · DOB 06/1980 · age 46 | 25–50% | 25–50% | 25-50% shares · 25-50% voting · trust interest | 30/04/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ADHDDEGREE LTD→ SC822923 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AGE ETERNAL LIMITED→ SC767087 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE SCOTLAND→ SC153343 · est 1994 · no financials extracted | — | — | — | — | 31y | — | — |
| AILSA CARE SERVICES LTD.→ SC272779 · est 2004 · no financials extracted | — | — | — | — | 21y | — | — |
| ALL CARE SERVICES LTD→ SC599935 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALMOND VALLEY CARE LIMITED→ SC733638 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ALPHAMED SCOTLAND LIMITED→ SC688804 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ALTAIR MEDICAL LIMITED→ SC711736 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AMAYA EYE-PAEDIATRICS LIMITED→ SC499845 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ANSWER PROJECT→ SC212773 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
| ANTICA LIMITED→ SC270177 · est 2004 · no financials extracted | — | — | — | — | 21y | — | — |
| APEX CLINICS (SCO) LIMITED→ SC828888 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.